Mettler Toledo Introduces Mechanical Analyzer
The Excellence Dynamic Mechanical Analyzer DMA 1, introduced by Mettler Toledo offers six different deformation modes to gauge materials performance.
The Excellence Dynamic Mechanical Analyzer DMA 1, introduced by Mettler Toledo at Pittcon 2013, offers six different deformation modes to gauge materials performance. The instrument can handle multiple dynamic and static measurements to characterize viscoelasticity, glass transition, softening, crystallization, and phase transformation, according to the press announcement.
Users can set the sample arm and analysis head at multiple angles based on sample nature and geometry. Rapid cooling to as low as -190 ºC with minimal liquid nitrogen consumption also helps improve sample throughput, reduce costs, and improve operator safety.
The linear variable differential transformer (LVDT) measures changes in length over a measurement range of ±1 mm with a mean resolution of 2 nm. The DMA 1 also offers the ability to operate in liquids or at specific relative humidity levels.
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.
